ROSEN, RELIABLE INVESTOR ADVISOR, Urges Cassava Sciences, Inc. Investors to Secure Advice Ahead of Security Class Action Deadline

0 0 2 minutes read

ROSEN, RELIABLE INVESTOR ADVISOR, Urges Cassava Sciences, Inc. Investors to Secure Advice Ahead of Security Class Action Deadline

New York, New York–(Newsfile Corp. – December 20, 2024) – WHY: The Rosen Law Firm, a global investor rights law firm, is reminding buyers of the securities of Cassava Sciences, Inc. (NASDAQ: NASDAQ: ) between February 7, 2024 and November 24, 2024, both dates inclusive (the “Class Period”), material February 10, 2025 deadline for plaintiff.

NOW: If you purchased Cassava securities during the Class Period you may be entitled to compensation without payment of any out-of-pocket costs or expenses through a contingency fee arrangement.

WHAT YOU NEED TO DO: To join the Cassava class action, visit or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information about the class action. A class action lawsuit has already been filed. If you wish to act as a lead plaintiff, you must remove the Court no later than February 10, 2025. The lead plaintiff is the organization representing the other members of the class directing the lawsuit.

WHY THE LAW WENT OUT: We encourage investors to select qualified advisors with a track record of success in leadership roles. Generally, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these companies are not responsible for the actions of the security department, but they are partners who send customers or partners with law firms who prosecute cases. Be wise in choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder exit litigation. The Rosen Law Firm won the largest securities class action settlement ever against a Chinese Company at the time. The Rosen Law Firm is ranked #1 by ISS Securities Class Action (WA:) Value services for securities class agreements in 2017. The company has been listed in the top 4 every year since 2013 and has returned hundreds of millions of dollars to investors. In 2019 alone the company secured more than 438 million from investors. In 2020, founding partner Laurence Rosen was named by Law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, the defendants during the Class Period created a false impression that they had reliable information regarding the Cassava drug opportunity and expected growth while minimizing the risk of potential drug failure. However, in reality, Cassava’s repeated statements of reliance on simufilam, Cassava’s lead drug candidate, and reliance on turning around statistically insignificant data from Phase 2 studies fell short of the reality of simufilam’s potential; Cassava had no drug that could stop the progression of Alzheimer’s disease, even when trying to treat only mild and moderate cases. When true information enters the market, the lawsuit claims that investors suffered damages.

To join the Cassava class action, visit Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action.

No Class Guaranteed. Until the class is certified, you are not represented by an attorney unless you retain it. You can choose the advice of your choice. You can also remain a member of the missing class and do nothing for now. The investor’s ability to participate in any potential future returns is not dependent on performance as the lead claimant.

Advocate advertising. Previous results do not guarantee the same result.

——————————

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/234704

Source link